Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2026 04:18 ET | Source: Research and Markets

Nuclear Medicine Market by Type, Application, Procedure, End User, and Region - Global Forecast to 2030

Dublin, June 02, 2026 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Market by Type, Application, Procedure, End User, and Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's...
June 01, 2026 02:00 ET | Source: Curium

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

Curium’s strategic investment of over €32 million will establish a European production line for 177Lu-PSMA-I&T, a therapeutic agent for patients with metastatic castration-resistant prostate...
June 01, 2026 01:00 ET | Source: IBA SA

IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production

Louvain-la-Neuve, Belgium – 01 June 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production...
June 01, 2026 01:00 ET | Source: IBA SA

IBA lance Cyclone® iKure, un cyclotron conçu pour la production d’Astate-211 à l’échelle industrielle

Louvain‑la‑Neuve, Belgique, le 1er juin 2026 — IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et premier fournisseur mondial de solutions...
April 21, 2026 11:30 ET | Source: SNS Insider pvt ltd

Global Radiopharmaceutical Theranostics Market Projected to Reach USD 6.93 Billion by 2035 – SNS Insider

Austin, United States, April 21, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Radiopharmaceutical Theranostics Market was valued at USD 2.42 billion in 2025 and is expected to reach USD...
April 02, 2026 11:58 ET | Source: Research and Markets

Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights, including...
March 20, 2026 02:00 ET | Source: IBA SA

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical...
March 20, 2026 02:00 ET | Source: IBA SA

Telix choisit le Cyclone® KIUBE d’IBA pour étendre ses capacités de production aux États‑Unis

Louvain‑la‑Neuve, Belgique, le 20 mars 2026 — IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et premier fournisseur mondial de solutions de...
February 19, 2026 07:33 ET | Source: Research and Markets

Radioligand Therapy Market to Surge with 13.1% CAGR: Projected Growth from $2.6B in 2025 to $4.8B by 2030 - Novartis' Pluvicto and Lutathera Have Catalyzed Commercial Momentum

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Radioligand Therapeutics in Cancer Treatment: Global Markets" has been added to ResearchAndMarkets.com's offering.The global market for radioligand...
February 19, 2026 01:00 ET | Source: IBA SA

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India

Louvain-la-Neuve, Belgium – 19 February 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, and...